BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21197536)

  • 1. Effect of levosimendan and predictors of recovery in patients with peripartum cardiomyopathy, a randomized clinical trial.
    Biteker M; Duran NE; Kaya H; Gündüz S; Tanboğa HÎ; Gökdeniz T; Kahveci G; Akgün T; Yildiz M; Õzkan M
    Clin Res Cardiol; 2011 Jul; 100(7):571-7. PubMed ID: 21197536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful use of levosimendan in a patient with peripartum cardiomyopathy.
    Benlolo S; Lefoll C; Katchatouryan V; Payen D; Mebazaa A
    Anesth Analg; 2004 Mar; 98(3):822-4, table of contents. PubMed ID: 14980944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of levosimendan on right ventricular function in patients with advanced heart failure.
    Parissis JT; Paraskevaidis I; Bistola V; Farmakis D; Panou F; Kourea K; Nikolaou M; Filippatos G; Kremastinos D
    Am J Cardiol; 2006 Dec; 98(11):1489-92. PubMed ID: 17126656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Randomized Blinded Study of the Left Ventricular Myocardial Performance Index Comparing Epinephrine to Levosimendan following Cardiopulmonary Bypass.
    Salgado Filho MF; Barral M; Barrucand L; Cavalcanti IL; Verçosa N
    PLoS One; 2015; 10(12):e0143315. PubMed ID: 26655803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction.
    Haghikia A; Schwab J; Vogel-Claussen J; Berliner D; Pfeffer T; König T; Zwadlo C; Moulig VA; Franke A; Schwarzkopf M; Ehlermann P; Pfister R; Michels G; Westenfeld R; Stangl V; Kühl U; Podewski E; Kindermann I; Böhm M; Sliwa K; Hilfiker-Kleiner D; Bauersachs J
    Clin Res Cardiol; 2019 Mar; 108(3):290-297. PubMed ID: 30121697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Medical Treatment of New-Onset Peripartum Cardiomyopathy: A Systematic Review of Prospective Studies.
    Desplantie O; Tremblay-Gravel M; Avram R; Marquis-Gravel G; Ducharme A; Jolicoeur EM;
    Can J Cardiol; 2015 Dec; 31(12):1421-6. PubMed ID: 26160409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levosimendan improves hemodynamic status in critically ill patients with severe aortic stenosis and left ventricular dysfunction: an interventional study.
    García-González MJ; Jorge-Pérez P; Jiménez-Sosa A; Acea AB; Lacalzada Almeida JB; Ferrer Hita JJ
    Cardiovasc Ther; 2015 Aug; 33(4):193-9. PubMed ID: 25959786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predictive value of QRS duration in response to levosimendan therapy in patients with decompensated heart failure.
    Cetin M; Uçar O; Cicekçioğlu H; Güven Cetin Z; Sahin M; Vasfi Ulusoy F; Aydoğdu S
    Acta Cardiol; 2012 Jun; 67(3):317-23. PubMed ID: 22870740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of bromocriptine on left ventricular functional recovery in peripartum cardiomyopathy: insights from the BRO-HF retrospective cohort study.
    Tremblay-Gravel M; Marquis-Gravel G; Avram R; Desplantie O; Ducharme A; Bibas L; Pacheco C; Couture E; Simard F; Poulin A; Malhamé I; Tran D; Rey E; Tournoux F; Harvey L; Sénéchal M; Bélisle P; Descarries L; Farand P; Pranno N; Diaz A; Afilalo J; Ly HQ; Fortier A; Jolicoeur EM;
    ESC Heart Fail; 2019 Feb; 6(1):27-36. PubMed ID: 30565890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decongestive effects of levosimendan in cardiogenic shock induced by postpartum cardiomyopathy.
    Labbene I; Arrigo M; Tavares M; Hajjej Z; Brandão JL; Tolppanen H; Feliot E; Gayat E; Ferjani M; Mebazaa A
    Anaesth Crit Care Pain Med; 2017 Feb; 36(1):39-42. PubMed ID: 27436451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of sustained effects of levosimendan and dobutamine on left ventricular systolic functions by using novel tissue Doppler derived indices in patients with advanced heart failure.
    Oner E; Erturk M; Birant A; Kurtar Mansıroglu A; Akturk IF; Karakurt H; Yalcin AA; Uzun F; Somuncu MU; Yildirim A
    Cardiol J; 2015; 22(1):87-93. PubMed ID: 24846511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effects of levosimendan on the cardiac function and prognosis in elderly patients with septic shock and myocardial contractility impairment].
    Xu CX; Li L; Gong SJ; Yu YH; Yan J
    Zhonghua Nei Ke Za Zhi; 2018 Jun; 57(6):423-428. PubMed ID: 29925127
    [No Abstract]   [Full Text] [Related]  

  • 13. Right Ventricular Function in Peripartum Cardiomyopathy at Presentation Is Associated With Subsequent Left Ventricular Recovery and Clinical Outcomes.
    Blauwet LA; Delgado-Montero A; Ryo K; Marek JJ; Alharethi R; Mather PJ; Modi K; Sheppard R; Thohan V; Pisarcik J; McNamara DM; Gorcsan J;
    Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27166247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of early and delayed recovery in peripartum cardiomyopathy: a prospective study of 52 Patients.
    Biteker M; Özlek B; Özlek E; Çil C; Çelik O; Doğan V; Başaran Ö
    J Matern Fetal Neonatal Med; 2020 Feb; 33(3):390-397. PubMed ID: 29945487
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of levosimendan on left atrial functions in patients with ischemic heart failure.
    Duygu H; Nalbantgil S; Ozerkan F; Zoghi M; Akilli A; Erturk U; Akin M; Nazli C; Ergene O
    Clin Cardiol; 2008 Dec; 31(12):607-13. PubMed ID: 19072879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel marker of persistent left ventricular systolic dysfunction in patients with peripartum cardiomyopathy: monocyte count- to- HDL cholesterol ratio.
    Ekizler FA; Cay S
    BMC Cardiovasc Disord; 2019 May; 19(1):114. PubMed ID: 31092205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy.
    Haghikia A; Podewski E; Berliner D; Sonnenschein K; Fischer D; Angermann CE; Böhm M; Röntgen P; Bauersachs J; Hilfiker-Kleiner D
    Clin Res Cardiol; 2015 Nov; 104(11):911-7. PubMed ID: 26026286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up in peripartum cardiomyopathy patients with contemporary treatment: low mortality, high cardiac recovery, but significant cardiovascular co-morbidities.
    Moulig V; Pfeffer TJ; Ricke-Hoch M; Schlothauer S; Koenig T; Schwab J; Berliner D; Pfister R; Michels G; Haghikia A; Falk CS; Duncker D; Veltmann C; Hilfiker-Kleiner D; Bauersachs J
    Eur J Heart Fail; 2019 Dec; 21(12):1534-1542. PubMed ID: 31724271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of single-dose and repeated levosimendan infusion in patients with acute exacerbation of advanced heart failure.
    Tasal A; Demir M; Kanadasi M; Bacaksiz A; Vatankulu MA; Sahin DY; Eker RA; Bozkurt A; Acarturk E
    Med Sci Monit; 2014 Feb; 20():276-82. PubMed ID: 24549281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective use of levosimendan in anthracycline-induced cardiomyopathy: A case report.
    Miaris N; Zezas S; Sgouros J; Zirou DC; Gkoura S; Stamoulis G; Angelopoulou H; Avgeropoulos G; Samantas E
    Heart Lung; 2017; 46(5):382-386. PubMed ID: 28733066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.